Ruxolitinib Cream for the Treatment of Patients With Alopecia Areata: A 2-Part, Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study: Appendix

Published: 7 October 2019| Version 1 | DOI: 10.17632/8kg76m3zvr.1
Contributors:
Elise Olsen, Deanna Kornacki, Kang Sun, Maria Hordinsky

Description

Supplemental table I and supplemental figures 1 and 2.

Files

Categories

Health Sciences

Licence